To broaden and advance capabilities to offer imaging biomarker analysis
Subscribe to our email newsletter
Chondrometrics and Boston Imaging Core Lab (BICL) have formed a partnership to broaden and advance their capabilities for offering imaging biomarker analysis to osteoarthritis researchers in academia and pharmaceutical industry.
Dr. Guermazi, president, BICL, said: We are excited about this partnership and look forward to extending our already strong research collaboration into a closer strategic co-operation between the two companies.
Dr. Eckstein, CEO of Chondrometrics, said: This will allow us to offer the full spectrum of osteoarthritis imaging biomarkers, both quantitative and semi-quantitative, which recent research has been proven to provide complimentary and synergistic rather than competing or overlapping information in clinical trials.
Chondrometrics is a provider of software-based quantitative medical image analysis, with a focus on articular cartilage and other joint structures in osteoarthritis.
BICL is a provider of semi-quantitative radiological reading services, which are based on advanced radiological scoring systems, including all relevant joint tissues affected by osteoarthritis.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.